Pten in stromal fibroblasts suppresses mammary epithelial tumours

Nature

Volumn 461, Issue 7267, 2009, Pages 1084-1091

  Trimboli, Anthony J ^a   Cantemir Stone, Carmen Z ^a   Li, Fu ^a   Wallace, Julie A ^a   Merchant, Anand ^a   Creasap, Nicholas ^a   Thompson, John C ^a   Caserta, Enrico ^a   Wang, Hui ^a   Chong, Jean Leon ^a   Naidu, Shan ^a   Wei, Guo ^a   Sharma, Sudarshana M ^a   Stephens, Julie A ^a   Fernandez, Soledad A ^a   Gurcan, Metin N ^a   Weinstein, Michael B ^a   Barsky, Sanford H ^a,g,h   Yee, Lisa ^a   Rosol, Thomas J ^a   Stromberg, Paul C ^a   Robinson, Michael L ^b,g,i   Pepin, Francois ^c,d   Hallett, Michael ^c,d   Park, Morag ^c,e   Ostrowski, Michael C ^a,f   Leone, Gustavo ^a,f   more..

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f OHIO STATE UNIVERSITY   (United States)

^g UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^h NEVADA CANCER INSTITUTE   (United States)

ⁱ MIAMI UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TRANSCRIPTION FACTOR ETS 2;

CANCER; CYTOLOGY; GENE EXPRESSION; IMMUNE SYSTEM; MAMMAL; MEDICINE; TUMOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; CANCER INHIBITION; CARCINOGENESIS; CELL INFILTRATION; CONTROLLED STUDY; EPITHELIUM TUMOR; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION PROFILING; GENE INACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MALIGNANT TRANSFORMATION; MAMMARY GLAND; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; STROMA CELL; TUMOR GROWTH;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; EXTRACELLULAR MATRIX; FIBROBLASTS; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNITY, INNATE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; NEOPLASMS, GLANDULAR AND EPITHELIAL; PROTO-ONCOGENE PROTEIN C-ETS-2; PTEN PHOSPHOHYDROLASE; STROMAL CELLS;

EID: 70350510924     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature08486     Document Type: Article

References (49)

1. Wiseman, B. S. & Werb. Z. Stromal effects on mammary gland development and breast cancer. Science 296,1046-1049 (2002).
2. Nelson, C. M. & Bissell, M. J. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 22, 287-309 (2006).
3. Mueller. M. M. & Fusenig. N. E. Friends or foes - bipolar effects of the tumour stroma in cancer. Nature Rev. Cancer 4, 839-849 (2004).
4. Schedin, P. Pregnancy-associated breast cancer and metastasis. Nature Rev. Cancere, 281-291 (2006).
5. Littlepage. L E., Egeblad. M. & Werb, Z. Coevolution of cancer and stromal cellular responses. Cancer Cell 7, 499-500 (2005). (Pubitemid 40799241)
6. Bhowmick, N. A., Neilson, E. G. & Moses, H. L Stromal fibroblasts in cancer initiation and progression. Nature 432, 332-337 (2004). (Pubitemid 39551661)
7. Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nature Rev. Cancer 6, 392-401 (2006).
8. Cully, M., You, H., Levine, A. J. & Mak, T. W. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nature Rev. Cancer 6,184-192 (2006). (Pubitemid 43292562)
9. Bergamaschi, A. et al. Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. J. Pathol. 214,357-367 (2008). (Pubitemid 351212391)
10. Myers, M. P. et al. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc. Nati Acad. Sci. USA 95,13513-13518 (1998).
11. Stambolic, V. et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29-39 (1998). (Pubitemid 28458022)
12. Salmena, L, Carracedo, A. & Pandolfi, P. P. Tenets of PTEN tumor suppression. Cell 133, 403-414 (2008).
13. Knobbe, C. B., Lapin, V., Suzuki, A. & Mak, T. W. The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey. Oncogene 27, 5398-5415 (2008).
14. Di Cristofano, A., Pesce, B., Cordon-Cardo, C. & Pandolfi, P. P. Pten is essential for embryonic development and tumour suppression. Nature Genet 19, 348-355 (1998). (Pubitemid 28357906)
15. Trimboli, A. J. et al. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res. 68, 937-945 (2008).
16. Guy. C. T. et al. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad. Sci. USA 89, 10578-10582 (1992).
17. Cases, S. et al. Development of the mammary gland requires DGAT1 expression in stromal and epithelial tissues. Development 131,3047-3055 (2004). (Pubitemid 39077430)
18. Andrechek, E. R. et al. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. Proc. Natl Acad. Sci. USA 97, 3444-3449 (2000).
19. Desai, K. V. et al. Initiating oncogenic event determines gene-expression patterns of human breast cancer models. Proc. Natl Acad. Sci. USA 99,6967-6972 (2002).
20. Mootha, V. K. et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genet 34, 267-273 (2003).
21. Dennis, G., Jr et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4, 3 (2003).
22. Huang, D. W., Sherman, B.T.&Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 4, 44-57 (2009).
23. Weng, L P., Brown, J. L, Baker, K. M., Ostrowski, M. C. & Eng, C. PTEN blocks insu I in-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway. Hum. Mol. Genet 11,1687-1696 (2002). (Pubitemid 34812090)
24. Fowles, L. F. et al. Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/cfms signaling. Mol. Cell. Biol. 18, 5148-5156 (1998).
25. McCarthy, S. A. et al. Rapid phosphorylation of Ets-2 accompanies mitogenactivated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol. Cell. Biol. 17, 2401-2412 (1997).
26. Smith, J. L et al. ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice. Mol. Cell. Biol. 20, 8026-8034 (2000). (Pubitemid 30777720)
27. Watabe, T. et al. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int. J. Cancerll, 128-137 (1998).
28. Wei, G. et al. Activated Ets2 is required for persistent inflammatory responses in the motheaten viable model. J. Immunol. 173,1374-1379 (2004). (Pubitemid 38924318)
29. Ludwig, T. Local proteolytic activity in tumor cell invasion and metastasis. Bioessays 27,1181-1191 (2005).
30. Wei, G. et al. Etsl and Ets2 are required for endothelial cell survival during embryonic angiogenesis. Blood 114,1123-1130 (2009).
31. Lin, E. Y. et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am. J. Pathol. 163,2113-2126 (2003).
32. Yamamoto, H. et al. Defective trophoblast function in mice with a targeted mutation of Ets2. Genes Dev. 12,1315-1326 (1998).
33. Lee. S., Jilani, S. M., Nikolova, G. V., Carpizo, D. & Iruela-Arispe, M. L. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J. Cell Biol. 169, 681-691 (2005). (Pubitemid 41002860)
34. Millauer, B. et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-846 (1993). (Pubitemid 23110226)
35. Sakurai, Y., Ohgimoto, K., Kataoka, Y., Yoshida, N. & Shibuya, M. Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc. Natl Acad. Sci. USA 102,1076-1081 (2005).
36. Dakappagari, N. K. et al. Conformational HER-2/neu B-cell epitope peptide vaccine designed to incorporate two native disulfide bonds enhances tumor cell binding and antitumor activities. J. Biol. Chem. 280, 54-63 (2005).
37. Finak, G. et al. Stromal gene expression predicts clinical outcome in breast cancer. Nature Med. 14, 518-527 (2008). (Pubitemid 351655218)
38. Berns, K. et al. A functional genetic approach identifies the Pl3K pathway as a major determinant of trastuzumab resistance in breast cancer. Cancer Cell 12, 395-402 (2007). (Pubitemid 47539306)
39. Saal, L. H. et al. Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nature Genet 40,102-107 (2008).
40. Saal, L. H. et al. Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity. Proc. Natl Acad. Sci. USA 104,7564-7569 (2007).
41. Tynan, J. A., Wen, F., Muller, W. J. & Oshima, R. G. Ets2-dependent microenvironmental support of mouse mammary tumors. Oncogene 24, 6870-6876 (2005). (Pubitemid 41509410)
42. Buggy, Y. et al. Ets2 transcription factor in normal and neoplastic human breast tissue. Eur. J. Cancer 42,485-491 (2006). (Pubitemid 43227927)
43. Park, E. S. et al. Heterologous tissue culture expression signature predicts human breast cancer prognosis. PLoS One 2, e145 (2007).
44. Svensson, S. et al. ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis. Oncogene 24,4370-4379 (2005). (Pubitemid 40961760)
45. Pap, T. et al. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res. 2, 59-64 (2000). (Pubitemid 32223701)
46. White, E. S. et al. Negative regulation of myofibroblast differentiation by PTEN (phosphatase and tensin homolog deleted on chromosome 10). Am. J. Respir. Crit Care Med. 173,112-121 (2006).
47. Gibson, G. E & Huang, H. M. Oxidative processes in the brain and non-neuronal tissues as biomarkers of Alzheimer's disease. Front Biosci. 7, d1007-d1015 (2002).
48. Allred. D. C, Harvey, J. M., Berardo, M. & Clark, G. M. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod. Pathol. 11, 155-168 (1998).
49. Soule, H. D. & McGrath. C. M. A simplified method for passage and long-term growth of human mammary epithelial cells. In Vitro Cell. Dev. Biol. 22,6-12 (1986).